Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Evnin Luke
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   330,044    

Indirect Shares

   35,767,143      
Direct Value   $449,921    

Indirect Value

   $120,833,870      
Total Shares   36,097,187      
Total Value   $121,283,791      


iPass Inc $0 Tcr2 Therapeutics Inc. $449,921 iPass Inc $0 Tcr2 Therapeutics Inc. $449,921
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Oscient Pharmaceuticals Corp OSCIQ Director 0 2006-01-05 2,272,935    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 2004-07-02 0 2004-07-02 1,833,597    Premium*  
            iPass Inc IPAS 10% Owner 2004-02-09 26,043 2004-02-09 262,533    Premium*  
            Hemosense Inc HEM 10% Owner 2005-07-01 0 2007-11-06 0    Premium*  
            American Cryostem Corporation CRYO 10% Owner 2005-07-13 0 2005-07-19 2,931,531    Premium*  
            Radius Health Inc. RDUS Former 10% stockholder 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Director 2013-06-13 0 2013-06-13 824,255    Premium*  
            Syndax Pharmaceuticals Inc SNDX Director, 10% Owner 2016-03-08 0 2016-03-08 2,168,691    Premium*  
            Harpoon Therapeutics, Inc. HARP Former 10% Owner 2019-02-12 0 2021-04-15 3,220,844    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2020-06-23 3,003,772    Premium*  
            Oncorus, Inc. ONCR Director, 10% Owner 0 2020-10-06 2,492,843    Premium*  
            Turmeric Acquisition Corp. TMPM Chief Executive Officer 2020-10-20 0 2020-10-20 415,500    Premium*  
            Werewolf Therapeutics, Inc. HOWL Director, 10% Owner 0 2021-05-04 4,284,172    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2023-05-22 304,001 2023-05-22 3,370,977    Premium*  
* Premium Members only  

Records found :    107         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
IPAS iPass Inc 10% Owner   –       –       •   2004-02-09 4 D $0.00 $0 I/I (1,986,385) 262,533 -
IPAS iPass Inc 10% Owner   –       –       •   2004-02-09 4 A $0.00 $0 D/D 26,043 26,043 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-07-02 4 S $14.88 $116,786 I/I (7,847) 1,833,597 -
IDIX Idenix Pharmaceuticals In... 10% Owner   –       –       •   2004-07-27 4 S $14.00 $7,117,194 I/I (508,371) 4,797,991 -
HEM Hemosense Inc 10% Owner   –       –       •   2005-07-01 4 A $0.00 $0 I/I 3,537,359 3,537,359 -
HEM Hemosense Inc 10% Owner   –       –       •   2005-07-01 4 B $5.50 $4,214,980 I/I 766,360 4,303,719 1.5 -
CRYO American Cryostem Corpora... 10% Owner   –       –       •   2005-07-13 4 B $11.00 $1,980,000 I/I 180,000 180,000 1.5 -
CRYO American Cryostem Corpora... 10% Owner   –       –       •   2005-07-19 4 A $0.00 $0 I/I 2,722,381 2,902,381 -
CRYO American Cryostem Corpora... 10% Owner   –       –       •   2005-07-19 4 D $0.00 $0 I/I (92,790) 2,931,531 -
CRYO American Cryostem Corpora... 10% Owner   –       –       •   2005-07-19 4 OE $8.37 $1,020,638 I/I 121,940 3,024,321 -
OSCIQ Oscient Pharmaceuticals C... Former 10% owner   –       •      –    2005-08-15 4 S $2.61 $130,350 I/I (50,000) 7,482,050 -
OSCIQ Oscient Pharmaceuticals C... Former 10% owner   –       •      –    2005-08-16 4 S $2.64 $396,360 I/I (150,000) 7,332,050 -
OSCIQ Oscient Pharmaceuticals C... Former 10% owner   –       •      –    2005-08-17 4 S $2.66 $425,840 I/I (160,000) 7,172,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-08-18 4 S $2.53 $569,160 I/I (225,000) 6,947,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-08-19 4 S $2.35 $383,168 I/I (160,000) 6,787,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-08-22 4 S $2.28 $456,680 I/I (200,000) 6,587,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-08-24 4 S $2.23 $446,000 I/I (200,000) 6,387,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-08-30 4 S $2.28 $228,000 I/I (100,000) 6,287,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-08-31 4 S $2.30 $3,475,000 I/I (1,500,000) 4,787,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-06 4 S $2.47 $602,046 I/I (242,000) 4,545,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-09 4 S $2.51 $250,980 I/I (100,000) 4,445,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-12 4 S $2.44 $500,938 I/I (205,000) 4,240,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-13 4 S $2.44 $121,855 I/I (50,000) 4,190,050 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-14 4 S $2.45 $58,756 I/I (23,975) 4,166,075 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-16 4 AS $2.41 $252,588 I/I (105,000) 4,061,075 -
  107  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us